Main > NEUROLOGY. > Multiple Sclerosis > Treatment > Co: USA. A. DaclizuMAb Inj.



Co: USA. A. DaclizuMAb Inj.'s subsections
(*) CA Approval Date: 2016. 12.09.
(*) EU Approval Date: 2016. 07.05.
(*) USA Approval Date: 2016. 05.27.
(*) WW Withdrawal Date: 2018. 03.02
Company
Partner
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2007. 03.13.
TradeMark
TradeMark Web-Site

Co: USA. A. DaclizuMAb Inj.'s products
This section has no products